Chronic Treatment with Angiotensin II Type 1 Receptor Antagonist Suppresses Glomerular Activator Protein–1 Activity in Salt–Sensitive Hypertensive Rats

Publisher： Karger

E-ISSN： 1423-0143|23|1|35-41

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.23, Iss.1, 1999-10, pp. : 35-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prepubertal Treatment with Angiotensin Receptor Blocker Causes Partial Attenuation of Hypertension and Renal Damage in Adult Dahl Salt-Sensitive Rats

By  

Nephron, Vol. 91, Iss. 4, 2002-07 ,pp. : 710-718

Karger

Access to resources Recommend Favorite

Regression of Glomerular Injury by Kallikrein Infusion in Dahl Salt-Sensitive Rats Is a Bradykinin B2-Receptor-Mediated Event

By  

Nephron, Vol. 81, Iss. 2, 1999-02 ,pp. : 183-193

Karger

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Dietary Quercetin Augments Activator Protein-1 and Does Not Reduce Nuclear Factor-κB in the Renal Cortex of Rats with Established Chronic Glomerular Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 313-319

Karger

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy with an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitor on Overt Proteinuria in a Patient with Type 1 Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 529-530

Karger

Access to resources Recommend Favorite